#Mass Spectrometry Market Growth

[health-views-updates]

Mass Spectrometry Market Insights: Future Trends and Growth

Mass Spectrometry Market Outlook, Scope & Overview:

Industry reports indicate that the global mass spectrometry market was valued at USD 5,195.45 million in 2022 and is projected to reach USD 9,723.78 million by 2030, growing at a CAGR of 8.15% over the forecast period 2023-2030.

Technological Advancements to Drive Growth of Global Mass Spectrometry Market

The adoption of advanced mass spectrometry technologies will continue to influence global market revenues. Laboratories and research institutions are increasingly utilizing mass spectrometry for its high accuracy and sensitivity in detecting and quantifying molecules in complex mixtures.

As a product segment, hybrid mass spectrometry systems currently hold a significant share of the global mass spectrometry market. This segment is anticipated to grow at a year-over-year rate of 8.15% in 2023 over 2022 and reach USD 9,723.78 million in revenues by 2030. The increasing demand for precise analytical techniques in pharmaceuticals, biotechnology, and environmental testing is expected to drive market growth.

Get a Free Sample Report: https://www.snsinsider.com/sample-request/3835 

Mass Spectrometry Solutions – Market Dynamics

Drivers:

Mass spectrometry solutions are witnessing significant growth in the global market due to their ability to provide highly accurate and sensitive analysis of complex samples. The increasing adoption of mass spectrometry in proteomics, metabolomics, and drug discovery, coupled with advancements in mass spectrometry technology, are key factors driving the adoption of these solutions worldwide. Additionally, the rising demand for personalized medicine and the growing focus on biomarker discovery are further propelling market growth.

Restraints:

Despite the growth potential, challenges such as the high cost of mass spectrometry equipment, the need for specialized training and expertise to operate the instruments, and concerns about data accuracy and reproducibility are hindering the widespread adoption of mass spectrometry solutions. Moreover, the complexity of integrating mass spectrometry systems with existing laboratory workflows poses additional challenges to market expansion.

Mass Spectrometry Solutions – Market Outlook

The proven benefits of mass spectrometry solutions in providing precise and reliable analytical results, improving research outcomes, and enhancing drug development processes have contributed to the market's growth. Mass spectrometry solutions are expected to witness increased adoption across major markets, including North America, Europe, and Asia Pacific, driven by advancements in technology and the growing focus on high-throughput and high-resolution analytical techniques.

Global Mass Spectrometry Market

The rise in demand for mass spectrometry solutions in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global mass spectrometry market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of mass spectrometry solutions, supported by increasing investments in research and development and favorable regulatory frameworks.

Key Players in the Mass Spectrometry Solutions Market

Leading companies in the mass spectrometry solutions market include Agilent Technologies, Thermo Fisher Scientific, Waters Corporation, and Bruker Corporation. These companies are at the forefront of developing and commercializing advanced mass spectrometry platforms for various applications, including pharmaceuticals, biotechnology, environmental testing, and food safety.

In conclusion, the global mass spectrometry market is poised for substantial growth over the forecast period, driven by technological advancements, increasing research activities, and the expanding adoption of mass spectrometry solutions in diverse analytical applications.

Other Trending Reports

Online Pharmacy Industry Growth

Toxoid Vaccine Industry Growth

Healthcare EDI Industry Growth

Dental Practice Management Software Industry Growth

[medicaldevicesindustrynews]

The Perfect Guide to Mass Spectrometry

The Perfect Guide to Mass Spectrometry

Ionizing a sample and measuring the mass-to-charge ratios of the resultant ions are both possible using mass spectrometry (MS). The number of MS applications grows as a result of the mass spectrometer’s integration with computer technology and software. MS has been able to infiltrate a wide range of study domains, including biochemistry, chemistry, medicine, pharmacy, and many other relevant…

[credenceresearchdotblog]

The global Cell Surface Markers Market is poised for significant growth, with projections estimating an increase from USD 5,450 million in 2024 to USD 10,405.71 million by 2032, reflecting a compound annual growth rate (CAGR) of 8.42% over the forecast period. The global cell surface markers market has emerged as a cornerstone in biomedical research, diagnostics, and therapeutics. Cell surface markers—specific proteins or antigens present on the surface of cells—are critical in identifying and categorizing cell types, understanding immune responses, and diagnosing diseases. The market has witnessed robust growth due to advances in technologies such as flow cytometry, increasing research and development activities, and a surge in demand for precision medicine.

Browse the full report at https://www.credenceresearch.com/report/cell-surface-markers-market

Market Overview

The cell surface markers market encompasses instruments, reagents, and services used in research and clinical applications. The market is broadly segmented by product type, application, end-user, and geography. Key technologies driving the market include flow cytometry, immunohistochemistry, and mass spectrometry.

In terms of applications, the market is dominated by research on immunology and oncology. Immunological studies leverage cell surface markers to understand immune responses, while oncology research focuses on identifying tumor-specific markers for targeted therapies. The clinical diagnostics segment, particularly in hematology and autoimmune diseases, is also expanding rapidly.

Key Drivers of Market Growth

Rising Prevalence of Chronic Diseases Chronic diseases, such as cancer, diabetes, and autoimmune disorders, have seen a significant increase globally. This has heightened the demand for diagnostic tools and personalized medicine, where cell surface markers play a pivotal role. For example, CD markers are extensively used in diagnosing leukemias and lymphomas.

Technological Advancements Innovations in flow cytometry and mass spectrometry have revolutionized the analysis of cell surface markers, enabling higher accuracy, sensitivity, and throughput. Multicolor flow cytometry, for instance, allows the simultaneous analysis of multiple markers, facilitating comprehensive immunophenotyping.

Growing Investment in Research Governments and private organizations are increasingly funding life sciences research. This includes studies on cellular mechanisms, immune profiling, and cancer biology, all of which rely heavily on cell surface marker technologies.

Personalized Medicine and Immunotherapy The shift towards personalized medicine, particularly in oncology and autoimmune diseases, has amplified the importance of cell surface markers. These markers are critical in identifying patients who are most likely to respond to specific therapies, such as CAR-T cell therapy.

Market Challenges

Despite the growth prospects, the market faces several challenges:

High Costs of Instruments and Reagents: Advanced technologies like flow cytometers and their associated reagents are expensive, limiting accessibility, especially in developing regions.

Technical Complexity: The need for specialized expertise to operate instruments and analyze data remains a significant barrier.

Stringent Regulatory Requirements: The development and approval process for diagnostics and therapeutic applications involving cell surface markers is time-consuming and complex.

Future Outlook

The cell surface markers market is poised for significant growth, with a projected compound annual growth rate (CAGR) of over 8% during the forecast period (2023-2030). Key trends shaping the future of the market include:

Integration with Artificial Intelligence: AI-driven tools for data analysis are expected to enhance the accuracy and efficiency of cell surface marker studies.

Expansion of Applications: Beyond immunology and oncology, there is increasing interest in using cell surface markers in neurology, infectious diseases, and regenerative medicine.

Focus on Emerging Markets: Companies are likely to expand their footprint in emerging economies, leveraging local partnerships and tailored product offerings.

Key Player Analysis:

Becton, Dickinson and Company (BD)

Thermo Fisher Scientific, Inc.

Danaher Corporation

Merck KGaA

Bio-Rad Laboratories, Inc.

Agilent Technologies, Inc.

Miltenyi Biotec

Abcam PLC

Cell Signaling Technology, Inc.

Beckman Coulter, Inc.

Segmentations:

By Product

antibodies and PCR Arrays

mice

rats

other sources

By cell type

monocyte cell surface markers

NK cell surface markers

T cell surface markers

B cell surface markers

other cell types.

By application

research applications

clinical applications.

By end-user

hospitals & clinical testing laboratories

academic & research institutes

pharmaceutical & biotechnology companies.

Regional

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/cell-surface-markers-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

[marketsndata]

India Chromatography Instruments Market Size, Share, Growth and Forecast 2032

India chromatography instruments market is projected to grow at a CAGR of 7.50% from FY2025 to FY2032, increasing from USD 451.23 million in FY2024 to USD 804.76 million by FY2032. The market is anticipated to witness growth in the forecast period due to an increase in the demand for analytical solutions for precise healthcare outcomes. Investment in pharmaceutical research, high regulatory requirements for drug quality, and a focus on advanced diagnostics would drive chromatography adoption in the Indian healthcare sector.

Chromatography plays a significant role in drug delivery. Moreover, chromatographic techniques and equipment have become essential for biotechnological and pharmaceutical companies to develop pure drug molecules. It allows research to separate, analyze, and purify compounds and their mixtures efficiently. As drug development continues to rise in India, more advanced and analytical tools are required to support the entire new drug development process. This will create a demand for chromatography instruments with enhanced capabilities. Many industry leaders strategically partner with other companies to expand their analytical capabilities in India. For instance, in July 2023, Waters Corporation (Waters) acquired Wyatt Technology Corporation (Wyatt), to develop new analytical tools to aid drug processes. The coupling of Waters’ Liquid Chromatography (LC) instrumentation with Wyatt’s light-scattering technology enables Waters India to be more competent in supporting biopharma activities during drug development, manufacture, and quality control processes.

Rising Pharmaceutical R&D Investments to Support Market Expansion

Increased investment in pharmaceutical R&D is further driving the chromatography instruments market in India as demand for high-end analytical equipment increases support in drug development and quality checks. Recent initiatives such as Pharma Vision 2047 and research and development incentives have added pace to the generic drug manufacturing and novel therapeutics business of the Indian pharmaceutical industry. In such a scenario, the thrust now is on stringent regulatory standards, and there is an immense demand for chromatography instruments to study the complex nature of compounds, impurities, and active pharmaceutical ingredients. Investment in R&D between global pharmaceutical companies and Indian firms further intensifies this. As a result, the requirement for sophisticated analytical techniques like chromatography boosts the efficacy and accuracy of drug testing, quality assurance, and formulation processes. Also, in September 2023, to strengthen the research and developmental activities in the pharmaceutical and medical technology sectors, the government of India launched the Pharma and MedTech sector scheme of USD 61 million (INR 5,000 crore). Under this scheme, funding of more than USD 13.41 million (INR 1,100 crore) will be provided to nine pharmaceutical companies to undertake research work. The schemes are expected to collaborate between companies and academic institutions for pharmaceutical innovations.

Technological Advancements to Fuel Market Growth

Technological advancements in the chromatography instruments market are driven by the launch of more accurate, faster, and more sensitive reagents and resins. Advanced techniques, for instance, high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and gas chromatography-mass spectrometry (GC-MS), improve the detection of trace element as well as impurities detection in pharmaceutical, food safety, and environmental testing applications. Further innovations are noticed in automated systems and data integration, streamlining workflows, eliminating human error, and enhancing the efficiency of laboratories. Portable and miniaturized chromatography devices expanded the use of chromatography from typical lab settings to on-site tests. Such developments respond to quality control and regulatory requirements that have become more demanded by India’s industrial sectors. Integrating artificial intelligence (AI) technology into chromatography instrumentation improves lab efficiency and accuracy. For instance, in February 2023, Agilent Technologies, Inc. (Agilent) acquired AI technology developed by Virtual Control. The latter is a company that develops AI and machine learning software, including laboratory analysis. This technology automates complicated processes in chromatography and mass spectrometry data analysis through its software product called ACIES. It increases the speed of work to be executed, from preparation to reporting on samples in a laboratory. Agilent plans to integrate ACIES into the MassHunter LC/MS and GC/MS platforms, wherein the core members of the ACIES team will join Agilent.

High-Performance Liquid Chromatography (HPLC) to Hold Significant Market Share

The segment of high-performance liquid chromatography (HPLC) dominates India chromatography instruments market with a major share based on factors such as precision, versatility, and reliability in various applications. The ability of HPLC to carry out separation, identification, and quantification of complex mixtures makes it important in pharmaceuticals, food safety, and environmental testing. Advanced columns for HPLC are touted as the pursuit of achieving greater analytical accuracy. This pharmaceutical sector has stringent quality control standards, for which HPLC has been made a necessity for testing and validation of drugs. Ultra-high-performance liquid chromatography is a new advancement in this technology that offers faster analysis with lower solvent consumption, propelling the acceptance of the technology even more in the Indian market.

For instance, in May 2023, Anand Milk Union Limited (AMUL) opened the first-ever advanced lab specialized in testing organic food in Gandhinagar, Gujarat. The lab is equipped with advanced technologies, including HPLC, and others, such as Gas Chromatograph-Mass Spectrometer (GC-MS) and Liquid Chromatograph-Mass Spectrometer (LC-MS). These equipment can detect and quantify specific amounts of organic compounds, pesticides, herbicides, etc., in food samples. The lab tests for trace elements, heavy metals, mycotoxins, additives, and preservatives allow organic producers to work together with the best possible testing.

Download Free Sample Report

Future Market Scenario (FY2025 –FY2032F)

The market is expected to experience significant growth in the coming years due to the increased adoption of green chromatography techniques. The technique involves the use of an eco-friendly solvent and waste minimization. Emerging demand for miniaturized and portable chromatography systems for on-site testing of food safety, pharmaceuticals, and environmental monitoring. Artificial intelligence and machine learning analysis are increasingly being used, enhancing the results’ accuracy and speed.

The rising regulatory requirement for quality control in drug development fuels further demands for advanced chromatography solutions, ultimately providing immense market growth opportunities over the next few years. For instance, in January 2024, the Central Drugs Standard Control Organization (CDSCO) Sub Zonal Office and Central Drug Testing Laboratory (CDTL) was established in Indore, Madhya Pradesh. It will work towards strengthening the regulation of drugs, cosmetics, and medical devices in the area to deliver quality medicines in the country. This new CDTL comes with modern capabilities for up-to-date laboratories with 12 HPLC systems, where samples of medicines can be adequately tested and assured of quality.

Report Scope

“India Chromatography Instruments Market Assessment, Opportunities and Forecast, FY2018-FY2032F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of India chromatography instruments market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between FY2025 and FY2032. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Click here for full report- https://www.marketsandata.com/industry-reports/india-chromatography-instruments-market

Latest reports-

Contact

Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: info@marketsandata.com Website: https://www.marketsandata.com

[insightfulblogz]

High-Performance Liquid Chromatography Market Size, Latest Trends, Share, Growth Analysis, and Forecast 2032

High-performance liquid chromatography (HPLC) has become a gold standard in analytical chemistry, offering unmatched precision and versatility in separating, identifying, and quantifying chemical compounds. Widely utilized across industries, HPLC supports applications in pharmaceuticals, environmental testing, food safety, and biotechnology. With its ability to analyze complex mixtures and detect minute impurities, HPLC is a cornerstone of quality control and research, ensuring compliance with stringent regulatory standards.

The High-Performance Liquid Chromatography Market size was valued at USD 4.8 billion in 2023 and is expected to grow to USD 7.83 billion by 2031 and grow at a CAGR of 6.30% over the forecast period of 2024-2031.

Future Scope

The future of HPLC is closely tied to advancements in miniaturization, automation, and green technologies. Researchers are developing portable HPLC systems to enable on-site testing in fields such as environmental monitoring and clinical diagnostics. Efforts to reduce solvent consumption and adopt eco-friendly alternatives align with sustainability goals. Additionally, the integration of AI and machine learning is enhancing data analysis, improving efficiency and accuracy in chromatographic workflows.

Emerging Trends

Recent trends in HPLC include the adoption of ultra-high-performance liquid chromatography (UHPLC) for faster and more efficient separations. Innovations in column technology, such as sub-2-micron particle size materials, are improving resolution and sensitivity. Hybrid systems that combine HPLC with mass spectrometry (LC-MS) are gaining traction for advanced applications, including proteomics and metabolomics. Automated sample preparation and remote monitoring capabilities are further streamlining laboratory operations.

Applications

HPLC is indispensable in drug development and quality assurance in the pharmaceutical industry. It is extensively used for detecting contaminants and ensuring compliance in food and beverage production. Environmental testing relies on HPLC to monitor pollutants in air, water, and soil. In clinical diagnostics, it facilitates the analysis of biomarkers, enabling early disease detection and monitoring. Its applications extend to forensic science and material analysis, showcasing its versatility.

Key Points

HPLC is a precise analytical tool for separating and identifying compounds.

It is used across pharmaceuticals, food safety, and environmental testing.

Future innovations include portable systems and green technologies.

Trends emphasize UHPLC, hybrid systems, and AI-driven workflows.

Applications range from drug development to biomarker analysis.

Conclusion

High-performance liquid chromatography continues to evolve, meeting the growing demands of diverse industries with its precision and adaptability. As technology advances, HPLC is becoming more efficient, sustainable, and accessible, enabling breakthroughs in research and quality control. Its pivotal role in ensuring safety and compliance underscores its importance in modern science, solidifying its place as an essential analytical tool.

Read More Details: https://www.snsinsider.com/reports/high-performance-liquid-chromatography-market-3083 

Contact Us:

Akash Anand — Head of Business Development & Strategy

Email: info@snsinsider.com

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND) 

[amrutatbrc1]

Chromatography Software Market Report 2024-2033 | By Types, Applications, Regions And Players 

The chromatography software global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Chromatography Software Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The chromatography software market size has grown rapidly in recent years. It will grow from $1.19 billion in 2023 to $1.32 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%.  The growth in the historic period can be attributed to advancements in analytical techniques, rising need for automation, stringent regulatory requirements, increasing complexity of analytical processes, integration with laboratory information management systems (LIMS).

The chromatography software market size is expected to see rapid growth in the next few years. It will grow to $.96 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%.  The growth in the forecast period can be attributed to emergence of AI and machine learning integration, shift toward cloud-based solutions, focus on laboratory efficiency and productivity, integration with big data analytics, increased adoption of high-resolution mass spectrometry (HRMS). Major trends in the forecast period include automation and integration, cloud-based solutions, advanced data analysis, real-time monitoring, remote access and collaboration.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/chromatography-software-global-market-report

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers - The rising production of pharmaceuticals is expected to propel the chromatography software market going forward. The production of pharmaceuticals is a multifaceted outcome of evolving healthcare needs, scientific advancements, and market dynamics. The pharmaceutical industry relies on chromatography techniques for quality control and assurance during production. Chromatography software is critical in analyzing and interpreting chromatographic data, ensuring the quality and consistency of pharmaceutical products. For instance, in May 2021, according to reports published by IQVIA Inc., a US-based pharmaceutical company, the projected total expenditure on pharmaceuticals in the US is anticipated to range between $380 and $400 billion by the year 2025, up from $359 billion in 2020, reflecting a compound annual growth rate of 0-3%. Therefore, the rising production of pharmaceuticals is driving the growth of the chromatography software market.

Market Trends - Major companies operating in the chromatography software market are focused on developing advanced software solutions, such as clarity 9.0, a new version of chromatography software, to provide high-quality, efficient, and user-friendly solutions that meet the evolving needs of the pharmaceutical and analytical industries. For instance, in August 2023, DataApex, a Czechia-based software company, released Clarity 9.0, a new version of chromatography software. This latest version offers several enhancements and features compared to the previous version. The software provides a wide range of chromatogram modification capabilities, including the ability to overlay numerous chromatograms and electronically sign. It also supports networked solutions, allowing offline chromatogram evaluation and technique development. It additionally offers language localization in multiple languages and integration with LIMS for sample submission and result output.

The chromatography software market covered in this report is segmented –

1) By Software Type: Standalone Software, Integrated Software 2) By Deployment: Web Based, On-Premises, Cloud Based 3) By Version: Normal, Customized 4) By Application: Pharmaceutical industry, Environmental testing, Forensic testing, Food And Beverage Industry, Other Applications

Get an inside scoop of the chromatography software market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=14285&type=smp

Regional Insights - North America was the largest region in the chromatography software market in 2023. The regions covered in the chromatography software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies - Major companies operating in the chromatography software market are Hitachi, General Electric Company, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Mettler-Toledo International Inc., Shimadzu Corporation, Shimizu Corporation, Bio-Rad Laboratories, Inc., Bruker Corporation, Water Cooperation, JASCO Corporation, DataApex, Scion Instruments, KNAUER Wissenschaftliche Geräte GmbH, Gilson Incorporated., Axel Semrau GmbH & Co. KG, SEDERE, Restek Corporation, Cecil Instrumentation Services Ltd., Sykam GmbH, Antec Scientific, GoSilico GmbH, BUCHI Labortechnik GmbH

Table of Contents 1. Executive Summary 2. Chromatography Software Market Report Structure 3. Chromatography Software Market Trends And Strategies 4. Chromatography Software Market – Macro Economic Scenario 5. Chromatography Software Market Size And Growth ….. 27. Chromatography Software Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[global-research-report]

Exploring Regional Insights in the Proteomics Market: Trends and Predictions

The global proteomics market was valued at USD 24.29 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.10% from 2024 to 2030. This robust growth is driven by several key factors, including the rising prevalence of chronic and infectious diseases, the increasing demand for advanced diagnostic solutions for targeted disease treatment, and the growing need for personalized medicine. Additionally, technological advancements in protein analysis are further fueling the market's expansion, providing more precise tools for disease diagnosis and therapy.

Factors Driving Market Growth:

One of the primary drivers of the proteomics market is the increasing prevalence of chronic and infectious diseases worldwide. The World Health Organization (WHO) projects that the number of new cancer cases will rise to over 35 million by 2050, a 77% increase from the approximately 20 million cases anticipated in 2022. This surge in disease prevalence is spurring greater demand for pathogenesis research, as well as the development of advanced diagnostics and therapeutics. For example, a study published in Nature Communications in July 2024 highlighted how proteomics-based techniques were used to identify effectors secreted by Rickettsia spp., advancing our understanding of the host-pathogen interface.

Additionally, proteomics is playing a significant role in aging research. A study published in August 2024 in Nature Medicine introduced a proteomic aging clock, which uses plasma proteins to measure an individual's biological age. This tool can predict the risk of age-related diseases, multimorbidity, and even mortality across different populations. Emerging technologies like top-down proteomics are also enhancing our understanding of how proteoforms—distinct variations of proteins—contribute to disease mechanisms and precision medicine, helping to bridge the gap between genotypes (genetic makeup) and phenotypes (observable traits).

Gather more insights about the market drivers, restrains and growth of the Proteomics Market 

Regional Insights:

The global market for proteomics is experiencing strong growth across all regions, with significant contributions from North America, Europe, and the rapidly expanding Asia Pacific market.

North America:

In 2023, North America dominated the proteomics market, accounting for 45.97% of the total revenue share. This dominance can be attributed to the region’s advanced technological infrastructure, strong demand for disease diagnostics, and extensive research and development (R&D) investments, particularly in the fields of precision medicine and biotechnology. The presence of highly advanced healthcare facilities and substantial government funding for biotechnology and healthcare research further supports market growth in the region.

United States:

The U.S. proteomics market is expected to grow steadily throughout the forecast period, driven by its robust R&D landscape in biotechnology and life sciences. The U.S. is a leader in mass spectrometry technology, which has widespread applications in medicine, biotechnology research, and pharmaceutical development. Additionally, the presence of key players in the industry contributes to ongoing innovations, advancing proteomics research and its application in drug discovery, diagnostics, and personalized medicine.

Europe:

Europe is expected to experience significant growth in the proteomics market from 2024 to 2030, supported by a strong biotechnology R&D sector, an increasing focus on spatial biology research, and the presence of key industry players. Government investments, along with funding from private sources, are facilitating the expansion of proteomics research and driving the commercialization of proteomics products across the region.

United Kingdom:

The UK is poised for notable growth in the proteomics market due to advancements in mass spectrometry and its applications in a variety of fields, including oncology, neurology, immunology, pathology, and personalized medicine. The UK’s strong scientific community and healthcare infrastructure further support the adoption of proteomics technologies.

Germany:

Germany is witnessing substantial growth in the multi-omics field, which integrates proteomics with genomics, metabolomics, and other data types. The country has an active biotechnology and pharmaceutical sector, with strong support from academic institutions and government funding for proteomics-related research. For instance, the European Molecular Biology Laboratory (EMBL) in Germany hosted events in early 2024 focused on the integration and analysis of multiomics data, underscoring the country’s leadership in this area.

France:

In France, the proteomics market is expected to grow due to the increasing adoption of advanced protein analysis technologies in areas like cancer research, drug discovery, and translational research. Government funding and investments in biotechnology further support the market’s growth, positioning France as a key player in the European proteomics landscape.

Asia Pacific:

The Asia Pacific region is forecast to grow at the fastest CAGR of 15.97% from 2024 to 2030. Several factors contribute to this rapid growth, including the rising prevalence of chronic diseases, an increasing preference for outsourcing proteomics-based projects, and robust public and private funding for proteomics R&D. Additionally, favorable government regulations and the strong presence of biotechnology and biopharmaceutical companies in the region are driving market expansion.

Japan:

Japan’s proteomics market is expected to grow at a significant rate due to the country’s substantial investments in drug discovery and development, technological advancements, and the increasing focus on personalized medicine. Government policies supporting biotechnology innovation also contribute to market growth in Japan.

China:

China’s proteomics market is poised for growth, driven by the country’s focus on advancing biotechnology and therapeutics. The increasing demand for precision medicine, coupled with rising awareness of chronic diseases and the need for more effective diagnostic tools, is fueling the market’s expansion. Additionally, government investments in healthcare innovation and research are further propelling growth.

India:

India is expected to witness rapid growth in its proteomics market due to the increasing use of proteomics-based research and the growing presence of biopharmaceutical companies involved in drug discovery. Government investments in scientific research and healthcare innovation further boost the market’s expansion in the country.

Middle East and Africa:

The Middle East and Africa (MEA) region is expected to see growth in the proteomics market due to increasing demand for improved diagnostics that aid in the prevention and treatment of diseases, alongside rising government funding in biotechnology research. The region’s healthcare infrastructure development and focus on biotech innovation support market growth.

Saudi Arabia:

In Saudi Arabia, the proteomics market is expected to grow due to significant investments in biotechnology, increased research activities, and government initiatives aimed at advancing scientific research and innovation in health sciences.

Kuwait:

The proteomics market in Kuwait is anticipated to grow as the country engages in global collaborations with researchers and biotech companies. These partnerships facilitate the exchange of knowledge and access to advanced technologies, helping boost the market in Kuwait.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The Latin America molecular methods market for food safety testing size was valued at USD 154.6 million in 2024 and is projected to grow at a CAGR of 10.0% from 2025 to 2030.

The global plasma fractionation market sizewas estimated at USD 35.8 billion in 2024 and is projected to grow at a CAGR of 8.5% from 2025 to 2030.

Key Proteomics Companies:

The following are the leading companies in the proteomics market. These companies collectively hold the largest market share and dictate industry trends.

Illumina, Inc.

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific, Inc.

Bruker Corporation

F. Hoffmann-La Roche Ltd.

Waters Corporation

Merck KGaA

Danaher

Standard BioTools Inc.

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Global Expansion of Newborn Screening Market: What You Need to Know

The global newborn screening market was valued at USD 789.35 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.54% from 2023 to 2030. This growth is primarily driven by several factors, including an increasing neonatal population, a rising incidence of congenital diseases in newborns, heightened consumer awareness, and supportive initiatives from various governments that are implementing programs and legislations to promote newborn screening. Additionally, advancements in screening technologies are expected to further enhance market growth.

The growing prevalence of congenital diseases among newborns is anticipated to positively impact the newborn screening market. According to data released by the World Health Organization (WHO) in February 2023, approximately 240,000 newborns worldwide die within the first 28 days of life each year due to congenital conditions. These disorders are also linked to around 170,000 child deaths annually among those aged between one month and five years. Furthermore, research from Indian Pediatrics indicates that congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, with the prevalence of inborn metabolic disorders ranging from 2% to 7.8%. The significant occurrence of congenital diseases in newborns is likely to drive the demand for testing, thereby accelerating market growth by 2030.

Gather more insights about the market drivers, restrains and growth of the Newborn Screening Market

Technology Insights

In 2022, the tandem mass spectrometry segment emerged as the dominant force in the newborn screening market, capturing 24.5% of the overall revenue share. This leadership position can be attributed to several key factors, including its cost-effectiveness, broader applicability across various testing scenarios, and continuous technological advancements. Tandem mass spectrometry (MS/MS) is particularly valued for its ability to efficiently diagnose a wide range of medical conditions in a single testing procedure, making it an invaluable tool in newborn screening.

The efficiency of tandem mass spectrometry allows healthcare professionals to conduct comprehensive screenings that can identify multiple disorders simultaneously, thereby facilitating timely interventions. As the healthcare landscape evolves, the demand for rapid and accurate diagnostic tools has surged. This trend is likely to propel the tandem mass spectrometry segment to experience substantial growth, with a significant compound annual growth rate (CAGR) projected over the coming years. The innovative advancements being made by key market players are also expected to contribute to this growth. For example, in April 2023, Waters Corporation unveiled its new Xevo TQ Absolute IVD Mass Spectrometer, designed specifically for clinical applications. This product exemplifies the continuous push for technological enhancements that not only improve diagnostic accuracy but also streamline laboratory workflows.

In addition to tandem mass spectrometry, the electrophoresis segment is anticipated to see notable demand, projecting an impressive CAGR of 8.09% throughout the forecast period. The increasing emphasis on early detection techniques in healthcare is a primary driver behind this growth. Early diagnosis is crucial in managing congenital diseases effectively, as it allows for timely treatment and better health outcomes for newborns. Consequently, as healthcare providers and institutions prioritize early intervention strategies, the demand for electrophoresis is expected to rise correspondingly.

The growth of the electrophoresis segment is further supported by a surge in collaborations among various market players. Such partnerships often lead to innovative solutions that enhance product offerings and broaden market reach. For instance, in October 2022, CMP Scientific Corp. entered into a co-marketing agreement with Agilent to promote its advanced electrophoresis system. This collaboration not only aims to improve the technological capabilities of electrophoresis solutions but also focuses on expanding accessibility to these crucial diagnostic tools in newborn screening programs.

Moreover, the increasing focus on research and development in the field of newborn screening technologies is set to further enhance the capabilities of both tandem mass spectrometry and electrophoresis. As new methodologies and products are introduced, healthcare providers will be better equipped to address the complexities associated with congenital diseases. The integration of advanced technologies is expected to foster innovation, leading to more efficient, reliable, and cost-effective solutions for newborn screening.

Order a free sample PDF of the Newborn Screening Market Intelligence Study, published by Grand View Research.

[health-views-updates]

Vitamin D Testing Market Report: Revenue & Top Players Analysis 2024-2032

The Vitamin D Testing Market Revenue was valued at USD 31.5 billion in 2023 and is expected to grow to USD 47.32 billion by 2031, registering a steady CAGR of 5.2% during the forecast period of 2024 to 2031. The increasing awareness of the importance of vitamin D in overall health, rising prevalence of vitamin D deficiency, and advancements in testing technologies are key factors driving the market growth.

Market Growth Drivers

The rise in chronic diseases, such as osteoporosis and cardiovascular disorders, has underscored the critical role of vitamin D in preventing and managing these conditions. Increased public awareness campaigns and proactive healthcare initiatives have led to a surge in vitamin D testing, particularly in regions with higher risk of deficiency due to limited sunlight exposure or dietary insufficiencies.

The adoption of advanced testing technologies, such as liquid chromatography-mass spectrometry (LC-MS) and immunoassays, has further enhanced the accuracy and efficiency of vitamin D diagnostics. Additionally, the growing trend of at-home test kits has made vitamin D testing more accessible and convenient for consumers.

Regional Insights

North America dominates the vitamin D testing market, driven by high healthcare expenditure, widespread awareness, and advanced diagnostic infrastructure. Europe follows closely, with a significant population being at risk of vitamin D deficiency due to geographic and lifestyle factors. The Asia-Pacific region, on the other hand, is expected to witness the fastest growth owing to increased healthcare spending, rising awareness, and government initiatives promoting preventive care.

Get Free Sample Report@ https://www.snsinsider.com/sample-request/2621

Future Prospects

The vitamin D testing market is poised for steady growth as healthcare providers increasingly emphasize preventive diagnostics to manage deficiencies and associated health conditions. Innovations in testing methods, coupled with the integration of artificial intelligence and telemedicine, are expected to revolutionize the market, offering faster, more accurate, and cost-effective solutions. Furthermore, the expansion of healthcare services in emerging economies presents significant opportunities for market players.

About Us

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us

Akash Anand – Head of Business Development & Strategy Email: info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

[research2168]

Unveil Growth in the Global Certified Reference Materials Market

Market Overview

The worldwide Certified Reference Materials (CRMs) market is predicted to grow at a CAGR of 6.8% from 2024 to 2031, driven by increasing quality control and assurance needs across sectors. Stringent regulatory regulations, notably in the pharmaceutical and environmental sectors, are driving the implementation of CRM. Furthermore, increased focus on food safety and the growth of research facilities are helping to expand the industry.

Market Trends

The demand for matrix-matched CRMs is gaining traction in the industry, as these materials provide more accurate and reliable results for sample analysis of complex matrices. Matrix-matched CRMs simulate real sample sets better and enable more precise calibration and validation of analytical methods. Manufacturers are investing in developing matrix-compliant CRMs to meet the specific needs of various sectors and analytical approaches, driving market growth as labs seek to improve the accuracy of their analytical results.

Market Segmentation

Organic Certified Reference Materials (CRMs) hold the largest market share, driven by increasing demand in pharmaceutical, food, and environmental testing applications. These CRMs are essential for analyzing organic solids, pesticides, chemicals, and contaminants in food. The focus on food safety, pharmaceutical manufacturing, and environmental monitoring has significantly increased the demand for organic CRMs. Advances in analytical techniques such as chromatography and mass spectrometry have further expanded their applications, contributing to their market leadership.

Know More: Download Sample

[trendingrepots]

Molecular Diagnostics Market - Forecast, 2024 - 2030

Molecular Diagnostics Market Overview

The Molecular Diagnostics Market Size is forecast to reach $ 3240.4 Million by 2030, at a CAGR of 8.60% during forecast period 2024-2030. Molecular diagnostics can be demarcated as a group of techniques proficient in identifying specific genetic disparities in patients by using diverse technologies such as polymerase chain reaction, single nucleotide polymorphisms, electrophoresis, isothermal nucleic acid amplification technology, mass spectrometry to scrutinize biomarkers in the genome. Molecular diagnostics allows doctors to select an unsurpassed form of therapy by supporting the detection of maladies and possible risks. Moreover, it helps medical professionals to chart individualized or customer-specific plans. Therefore, accurate prescription and treatment duration help patients circumvent lengthy recapitulations of pointless drugs being used on patients recurrently with hostile effects. Besides cancer monitoring, molecular diagnostic can be used to manage infections like methicillin-resistant staphylococcus. Nevertheless, rising incidences of infections and cancer, augmenting health attentiveness among people, hiking demand for personalized medicines, and enlarging research and developmental activities are the factors set to drive the growth of the Molecular Diagnostics Industry for the period 2024-2030.

 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞

Report Coverage

The report: “Molecular Diagnostics Market Forecast (2024-2030)” by Industry ARC covers an in-depth analysis of the following segments of the Molecular Diagnostics Market.

By Product: Reagents, Instrument, and other devices.

By Application: Leukocyte Antigen Typing, Oncology, Blood screening, Transferrable ailments, and Others.

By Technology: TMA, In Situ Hybridization, PCR, DNA sequencing, INAAT, and Others.

By End User: Hospitals, Laboratories, CROs, and Other medical facilities.

By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

Geographically, North America’s Molecular Diagnostics Market accounted for the highest revenue share in 2021. The growth is owing to full-fledged healthcare infrastructure, the presence of top-notch pharmacy and biopharmaceutical companies, and the high disposable income of people. Furthermore, Asia-Pacific is poised to offer lucrative growth opportunities over the forecast period owing to rising disposable incomes and the higher class of the geriatric population, among many other reasons.

Intensifying cancer cases are said to be the preeminent driver driving the growth of the Molecular Diagnostics Market. The exorbitant cost of the associated treatments and instruments is said to reduce the market growth.

Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Molecular Diagnostics Market report.

[communicationblogs]

Argon Gas Market — Forecast(2024–2030)

Argon Gas Market Overview

Argon Gas Market is forecast to reach $597.5 million by 2030, after growing at a CAGR of 5.2% during 2024–2030. Cryogenic fractional distillation and gas chromatography are the most common methods for producing argon gas. Rising consumption and demand from the growing metal manufacturing industry for argon gas, coupled with increasing industrialization, especially in emerging economies are the major factors expected to drive the growth of the Argon Gas Market. Due to the rising demand for argon gas in numerous application segments such as electronics, stainless steel, and fabricated metalworking, the Argon Gas Market is expected to grow globally. Furthermore, technological innovation such as the increasing use of electrospray ionization mass spectrometry in the healthcare industry is anticipated to create new opportunities for the growth of the global argon gas industry in the forecast era. Argon gas finds extensive use in electronics manufacturing, particularly in the production of semiconductors and other electronic components. The trend is driven by the need for a controlled atmosphere during processes like sputtering and plasma etching. 

Request Sample

The semiconductor industry’s continuous growth is propelling the demand for high-purity Argon, contributing to market expansion. The healthcare sector is increasingly adopting Argon gas for medical applications, including cryopreservation and laser surgeries. Argon’s inert properties make it suitable for preserving biological samples, while its use in medical lasers ensures precision and minimal tissue damage. With advancements in medical technology, the healthcare industry is becoming a significant consumer of Argon gas, driving market growth.

Impact of Covid-19

The consequences of the pandemic are altering Argon Gas Markets, as some manufacturers are either shutting down or reducing their supply due to a lack of demand from the downstream industry. Thus, this has led to a decline in the market growth for argon gas over the year 2020–21.

Argon Gas Market Report Coverage

The: “Argon Gas Market Report — Forecast (2024–2030)”, by IndustryARC, covers an in-depth analysis of the following segments of the Argon Gas Market.

By Grade: Food Grade, Industrial Grade, Scientific Grade, and Others

By Mixture: Argon-carbon dioxide, Argon-oxygen, Argon-nitrogen, Argon-hydrogen, and Others

By Function: Insulation, Illumination, and Cooling

By Application: Manufacturing & Fabrication, Lighting, 3-D printing, Lasers, Gas dischargetubes, Cinematography, Refrigeration, Windows, Tire

By End-Use Industry: Chemical Industry, Healthcare Industry, Transportation Industry, Food & Beverage Industry, Electrical & Electronics Industry, and Others

By Geography: North America (U.S, Canada, and Mexico), Europe (U.K., Germany, France, Italy, Netherlands, Spain, Russia, Belgium, and Rest of Europe), APAC (China, Japan, India, South Korea, Australia, Taiwan, Indonesia, Malaysia, and Rest of Asia Pacific), South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), and RoW (Middle East and Africa)

Inquiry Before Buying

Key Takeaways

● The Asia Pacific region dominated the argon gas market due to the rapidly growing fabrication industries and the rising demand for argon gas from the food & beverage and healthcare sectors.

● Increasing use of argon gas owing to its greater thermal protection properties than air, for filling the dry suits used for scuba diving is anticipated to increase the demand for the argon gas market in the forecast period.

● Since Argon gas provides the inert atmosphere needed for rapid material cooling and heating, it is used in the electronics industry for the manufacture of semiconductors, flat panels, solar PV cells and microelectronic devices.

● Rising cause of inert gas asphyxiation among the workers by the consumption of argon gas in the absence of oxygen is anticipated to decline the growth of the market.

Argon Gas Market Segment Analysis — By Grade

Industrial grade held the largest share in the argon gas market in 2023. In MIG and TIG welding methods and plasma cutting applications due to its high density and absolute inertness, industrial-grade argon gas is widely used as a welding gas. Industrial-grade argon gas is supplied in gas bottles and cylinders of various sizes to suit consumer needs. Industrial-grade argon gas has many different applications in many industries. The most common application is either in pure form or as part of different mixtures, as a shielding gas for arc welding. Industrial-grade argon gas is one of the major gases for incandescent (filament) lamps, phosphorescent tubes, and thyratron radio tubes used in filling mixtures. Thus, with the rising demand for industrial-grade argon gas, the overall market is anticipated to rise in the forecast period.

Argon Gas Market Segment Analysis — By Mixture

Argon-carbon dioxide mixture is widely used in the argon gas market. Argon-carbon dioxide is a colorless, odorless, and non-flammable gas mixture. Argon mixtures with carbon dioxide are universal and are ideal for low-treated and stainless steel welding. One of the key composite components of safe welding mixtures is argon. Protective gas protects the electrode, metal, and hot metal near the welding seam from the ambient air as well as enhances the welding process and increases the welding characteristics. Argon-carbon dioxide blends can be used to incorporate a large spectrum of material thicknesses with a number of metal transition modes. With the rising use of argon-carbon dioxide mixture due to its unique properties, the market for argon gas is estimated to rise over the projected period.

Argon Gas Market Segment Analysis — By Function

Insulation function is highly preferred in the argon gas market. Argon serves as a barrier to prevent the indoor heat from escaping, like most insulating materials. But unlike most gases, the higher density of argon has greater thermal efficiency. This slow-moving gas, keeping heat loss to a minimum, allows less convection. To improve the energy consumption and general performance of thermal windows, argon gas is used. Insulated windows that are filled with argon gas are less likely to produce condensation. This is particularly true in areas of high humidity, such as the kitchen and the bathroom. Although good energy conservation could be demonstrated by fogging on the exterior surface of the glass, excessive humidity could result in water damage. With argon, to prevent it from sweating, the middle and the edges of the window glass will remain above the dew mark.

Argon Gas Market Segment Analysis — By Application

Manufacturing & Fabrication sector held the largest share in the argon gas market in 2023 and is projected to grow at a CAGR of 4.7% during the forecast period 2024–2030. During arc welding, it is often used as a shielding gas, because it shields the metal that is being worked on from oxygen. TIG, which stands for ‘tungsten inert gas’, utilizes both pure argon and argon mixtures. Argon decreases the chromium losses in the manufacture of steel in a converter, ensuring the desired carbon content can be reached at a lower and lower temperature. In aluminum processing, argon is often used to extract and degasify hydrogen. Also, cryogenic fractional distillation is used for producing argon gas of high purity, which is further used for the manufacturing and fabrication of semiconductor devices. Therefore, the rising demand for argon gas from the manufacturing and fabrication sector will drive the market demand for argon gas to grow in the forecast period.

Buy Now

Argon Gas Market Segment Analysis — By End-Use Industry

Automotive industry held the largest share of the argon gas market in 2023. Argon, due to its inert properties, is used in a wide variety of applications to help improve quality as well as maximize performance and yield in the manufacture of automotive parts. Owing to its alluring properties such as reduction or elimination of surface oxidation, improvement in part quality, decreasing scrap, and increasing efficiency and yields, it is used in a wide range of applications across automotive component manufacturing such as for welding, thermal, and plasma spraying, 3D printing, quenching, and others. Also, the most exotic use of argon is in the tires of luxury vehicles. Not only does the gas shield the tires from an oxygen attack, but it also provides less tire noise while the vehicle is moving at speed. With the rising automotive industry, the application of argon gas in the production of automotive components will also increase. According to the Association of Automobile Manufacturers (CAAM), China’s auto exports reached a record high of 4.91 million vehicles in 2023, up 57.9 percent year over year, as the nation’s automakers increased their global footprint. Thus, the rising demand for argon gas from the automotive industry is further estimated to raise the market growth.

Argon Gas Market Segment Analysis — Geography

For More Details on This Report — Request for Sample

Argon Gas Market Drivers

Increasing Price of Helium is Driving the Demand for Argon as an Alternative for Various Applications

Helium is replaced by argon in various sectors. Due to the high cost relative to argon, which has low cost and also has large applications, rising helium prices are expected to propel argon demand in many regions. Argon is used instead of helium because of the rising demand in separate application categories, such as stainless steel, electronics, and industrial metalworking sectors. According to the Oil Prices News Article in 2023, Helium prices skyrocketed when expectations of an abundant supply were not met; depending on purity and grade, they can sell for $500 Mcf to $1,000/Mcf. Prices are still ambiguous and change from transaction to transaction. Argon may be replaced by helium in the welding process. Also, helium is commonly used as a shielding gas for non-ferrous welding. Instead of helium, argon may be used and is favored by some metal forms. Owing to the above factors, an increase in demand for argon as an alternative to helium will drive the market for argon gas in the forecast period.

Rising Demand for Argon Gas in the Healthcare Industry

Cryogenic fractional distillation is used for the production of large quantities of purified argon in the healthcare industry. Argon is a noble gas component that has shown valuable narcotic and defensive capability in the medical sector. In order to selectively kill small areas of diseased or unhealthy tissue, especially on the skin, Argon is used to conduct accurate cryosurgery, which requires intense cold. Very cold argon is generated by controlled expansion of argon gas at the site and is driven using a cryoneedle to the treatment stage. This gives the device greater control than older liquid nitrogen techniques. A similar technique, cryoablation, is used to treat heart arrhythmia by destroying cells that interfere with the normal distribution of electrical impulses. As an important technique in clinical laboratories, electrospray ionization mass spectrometry (ESI-MS) has arisen. The increasing growth of argon in healthcare industries is expected to influence major trends in the global argon gas market in the coming years.

Argon Gas Market Challenges

Health Effects of Argon Gas Acts as a Constraint Towards the Growth of the Market

Argon gas can be absorbed into the body through inhalation. This liquid evaporates very rapidly with the lack of containment, creating air supersaturation and a significant risk of suffocation while in confined areas. Argon gas has been categorized as simple inert gas asphyxiation. Excessive inhalation can lead to dizziness, nausea, vomiting, loss of consciousness, and death. Death can result from mistakes that prevent self-rescue in judgment, misunderstanding, or lack of consciousness. Unconsciousness and death can occur in seconds without warning at low oxygen concentrations. Also, contact with argon gas can irritate and burn the skin and eyes. Very high levels of argon can decrease the amount of oxygen in the air and cause suffocation with symptoms of headache, rapid breathing, and loss of coordination and judgment. Hence, various harmful effects of argon gas on humans will further create hurdles for the argon gas market in the forecast period.

Market Landscape

● Technology launches, acquisitions and R&D activities are key strategies adopted by players in the argon gas market. Major players in the argon gas market are Taiyo Nippon Sanso Corporation, The Linde Group, Iwatani Corporation, Messer Group GmbH, Air Liquid S.A., SABIC, BASF SE, Air Products, and Space Cryogases Private Limited. and Matheson Tri-Gas Inc. among others.

Acquisitions/Technology Launches

• In October 2023, Inox Air Products intends to invest between Rs 300 and Rs 500 crore to build a supply network and purifying facilities for gases used by Indian semiconductor production facilities. Inox Air Products has started making investments in the purification of raw gases, such as oxygen, nitrogen, argon, helium, nitrous oxide, methane, silane, and ammonia, that are currently available in India. We’ll transform these gases into ultra-high purity.

[trendingreportz]

Single-cell Genome Sequencing Market - Forecast(2024 - 2030)

Single-cell Genome Sequencing Market Overview 

The Single-cell Genome Sequencing size is estimated to reach $9 billion by 2030, growing at a CAGR of 16.2% during the forecast period 2023-2030. Single-cell genome sequencing is one of the major areas of research for finding a cure for chronic ailments such as cancer. The rising cases of cancer worldwide would drive the Single-cell Genome Sequencing Market during the forecast period. According to Cancer.org, the global burden of new cancer cases would grow to 27.5 million by 2040. This would certainly boost the demand for Single-cell Genome Sequencing Market to find a cure for such chronic diseases.

Rapid development in sequencing technologies is also expected to drive the growth of this market during the forecast period. Polymerase chain reaction (PCR) and next-generation sequencing are emerging as the preferred technologies for various applications, especially for single-cell genomic sequencing. In January 2022, a group of medical Scientists at Stanford and their collaborators developed a new ultra-fast genome sequencing approach that offered a diagnostic rate of about 12% higher than the average rate for diagnosing mystery illnesses.

Request Sample

Single-cell Genome Sequencing Market - Report Coverage:

The “Single-cell Genome Sequencing Market Report- Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Single-cell Genome Sequencing Market.AttributeSegment

By Product Type

Consumables

Reagents

By Technique

Flow Cytometry

Next-generation Sequencing

Polymerase Chain Reaction

Microscopy

Mass Spectrometry

Others

By Application

Cancer

Immunology

Microbiology

Others

By End-User

Academic and Research Laboratories

Hospitals and Diagnostic Centers

Biotechnology and Pharmaceutical Companies

Cell Banks and IVF Centers

By Geography

North America (the U.S., Canada and Mexico)

Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe),

Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific),

South America (Brazil, Argentina, Chile, Colombia and the Rest of South America)

The Rest of the World (the Middle East and Africa).

COVID-19 / Ukraine Crisis - Impact Analysis: 

The COVID-19 pandemic had a positive impact on the Single-cell Genome Sequencing Market. The studies on single-cell genome sequencing offered critical insights into coronavirus infection and allowed medical experts better understand the nature of the infection. On performing single-cell sequencing, most cell types in patients with COVID-19 showed a significant interferon-α response along with an overall acute inflammatory response.

 Russia’s invasion of Ukraine has made a significant impact on the Single-cell Genome Sequencing market. It has not only affected the lives and work of genomic researchers in these countries but has also influenced the relationships with colleagues in the U.S. and elsewhere.

The sanctions against Russia are most likely to bring experimental genomics research in the country to a halt. Ukraine had several genomics research projects going on before the war began. Now, with all the unrest, most researchers in Ukraine are fleeing the country and looking for positions in the west.

Inquiry Before Buying

Key Takeaways: 

Fastest Growth in the Asia-Pacific Region : Geographically, in the global Single-cell Genome Sequencing market share, Asia-Pacific is analyzed to grow with the highest CAGR of 17.2% during the forecast period 2023-2030. This growth is driven by the rising number of cancer cases in the region. According to the projections by the International Agency for Research on Cancer, there would be about 15.1 million new cases per year in Asia until 2040. The unprecedented rate of population aging is the key determinant of this development. Japan, the country with the oldest population in the world, also has the highest rate of cancer. This would drive growth in the Single-cell Genome Sequencing Market in the region during the forecast period.

Reagents Segment to Register the Fastest Growth : In the Single-cell Genome Sequencing analysis, the Reagents segment is estimated to grow with the highest CAGR of 17% during the forecast period. This is because the use of single-cell sequencing reagents allows the experts to process bulk samples with the input of as few as 100 cells. With the recent advancements in single-cell DNA sequencing techniques, bulk DNA sequencing can be done more efficiently and cost-effectively. Moreover, commercial reagents are now available for all the wet-lab steps of a scRNA-seq protocol as well as for preparing barcoded cDNA libraries. The increasing availability of reagents and their growing need in various single-cell genome sequencing processes are boosting its growth in the Single-cell Genome Sequencing Market during the forecast period.

Academic and Research Laboratories Segment is Leading the Market : According to the Single-Cell Genome Sequencing Market forecast, the academic and research laboratories segment held the largest market share of 38.6% in 2022. Single-cell genomics is emerging as one of the major areas in scientific research and development. The rising prevalence of chronic diseases demands new cures and treatment options, which is further boosting the growth of the academic and research laboratories segment. Moreover, understanding the genomics of individual cells opens up a new set of opportunities for the world of biotechnology.

Increased Funding for Vaccine Development and Production : Government agencies in various parts of the world have increased funding for the development and production of vaccines in response to the pandemic. This has led to increased use of single-cell analysis (SCA) tools for COVID-19 research. SCA helps in the assessment of the peripheral immune function of the disease and contributes to the study of the pathophysiology and treatment possibilities of the disease. Thus, the market is positively impacted by COVID-19.

Massive Demand in the field of Immunology, Oncology and Others : Single-cell technology is used in the molecular-level examination of processes and pathways of cellular heterogeneity along with its assessment. This rapidly developing technology has major applications in immunology, oncology and other major areas. Moreover, the development of advanced tools that help make proteomic and transcriptomic processes simpler is also driving the use of single-cell analysis methods, boosting the growth of the Single-cell Genome Sequencing Market.

High Cost of Instruments to Hinder Market Growth : While there is a significant demand for genome sequencing machines among the end-user industries, the instrument costs are significantly high. According to a report published in Bloomberg, Illumina’s new NovaSeq X series costs $985,000 for the base machine and $1.25 million for the advanced one. Such high cost of instruments are likely to hinder the growth of the Single-cell Genome Sequencing Market.

Schedule a Call

Key Market Players:

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Single-Cell Genome Sequencing Market.

The top 10 companies in this industry are listed below:

Standard BioTools Inc. (Maxpar®, Advanta™ Assays)

QIAGEN N.V. (QIAseq FX, REPLI-g)

Illumina, Inc. (NovaSeq, NextSeq)

F. Hoffmann-La Roche AG (AVENIO, MagNA Pure)

Thermo Fisher Scientific, Inc. (Invitrogen, Applied Biosystems)

Bio-Rad Laboratories, Inc. (SEQuoia, ddSEQ)

10X Genomics, Inc. (Chromium, Visium)

Becton, Dickinson and Company (BD Rhapsody™, BD AbSeq)

Oxford Nanopore Technologies Limited (MinION, GridION)

Beijing Genomics Institute Group (CardioGen, COLOTECT™)

 Buy Now

Scope of the Report:

Report MetricDetails

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

16.2%

Market Size in 2030

$9 billion

Segments Covered

Product Type, Technique, Application, End-user and Region

Geographies Covered

North America (the U.S., Canada and Mexico) Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe),Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and the Rest of the World (the Middle East and Africa).

Key Market Players

Standard BioTools Inc.

QIAGEN N.V.

Illumina, Inc.

F. Hoffmann-La Roche AG

Thermo Fisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

10X Genomics, Inc.

Becton, Dickinson and Company

Oxford Nanopore Technologies Limited

Beijing Genomics Institute Group

Pacific Biosciences of California, Inc.

NuGEN Technologies, Inc.

Novogene Co. Ltd.

Takara Bio, Inc.

Danaher Corporation